Disease/Infection News

RSS

New TB vaccine: mid-phase trials confirm safety, long-term prevention

A new study published on October 29, 2019, in the New England Journal of Medicine, reports a new vaccine which could change the face of tuberculosis prevention. The disease kills 1.5 million people worldwide each year.

30 Oct 2019

IU researcher receives NIH grant to perform clinical trial on cirrhosis

An Indiana University School of Medicine researcher has been awarded a five-year, $1.8 million grant from the National Institutes of Health for a clinical trial, aimed at providing new avenues to improve liver function for patients with alcoholic cirrhosis.

30 Oct 2019

Study sheds new light on mechanism behind evolution of antibiotic resistance

Researchers have provided new insight into a mechanism behind the evolution of antibiotic resistance in a type of bacterium that causes severe infections in humans.

29 Oct 2019

Study uses whole-genome sequencing for early identification and containment of AMR pathogens

A study published today in PNAS examines the evolutionary and epidemiologic history of an epidemic strain of extensively drug-resistant tuberculosis (XDR-TB) - called LAM4/KZN- in KwaZulu-Natal, South Africa.

29 Oct 2019

Pro-inflammatory protein could play key role in protecting against herpes virus

Researchers at the University of Arizona College of Medicine - Phoenix have discovered a function in a pro-inflammatory protein that could play an important part in improving current and future therapeutics for the herpes virus.

29 Oct 2019

Novel antibodies could provide a universal flu vaccine

Now, a new study published in the journal Science on October 25, 2019, reports on a set of three novel antibodies that bind to another type of viral cell surface antigen called neuraminidase (NA) that is necessary for viral replication.

28 Oct 2019

Horrifying HIV epidemic in Pakistani town children due to syringe reuse

Allegations abound in this small Pakistani town of Ratodero, in the province of Sindh. Stung by poverty, pediatricians, barbers and dentists alike brave the risk of transmitting fatal and incurable HIV infection by sharing the same needles, tools and blades for multiple patients and clients, without sterilizing them in between uses.

28 Oct 2019

Wild polio virus strain 3 finally conquered say scientists

World Polio day is observed on the 24th of October. This year on the day officials announced that one of the three strains of the wild polio virus has been finally wiped out due to persistent vaccination efforts across the globe.

26 Oct 2019

Newly identified antibodies could lead to better treatments and vaccines for influenza

A newly identified set of three antibodies could lead to better treatments and vaccines against influenza, according to a paper published this week in Science.

25 Oct 2019

Researchers find antibody that may protect against wide range of lethal influenza viruses

A nationwide team of researchers has found an antibody that protects mice against a wide range of potentially lethal influenza viruses, advancing efforts to design of a universal vaccine that could either treat or protect people against all strains of the virus.

25 Oct 2019

TB is not a life-long infection in most people

A new analysis challenges the longstanding notion that tuberculous infection is a life-long infection that could strike at any time and cause tuberculosis. Based on a review of clinical studies, researchers from the Perelman School of Medicine at the University of Pennsylvania and colleagues show that people who test positive with immunologic TB skin or blood tests rarely develop TB.

25 Oct 2019

New analysis provides insight into dangerous conditions in U.S. immigrant detention centers

An analysis and related commentary published in Clinical Infectious Diseases today provide in-depth examination of the deplorable and dangerous conditions in U.S. immigrant detention centers where seven children have died in the last 10 months.

25 Oct 2019

Pharma sells states on ‘Netflix model’ to wipe out hep C. But at what price?

When a long, black bus bearing the logo of drugmaker AbbVie rolls through Washington state next year, it will promote a new effort to eradicate hepatitis C infections.

25 Oct 2019

Scientists make breakthrough in the hunt for new C. diff vaccine

Scientists have made a breakthrough in the hunt for a new vaccine for killer hospital bug Clostridioides difficile (C. diff).

25 Oct 2019

UAB physicians encourage everyone to get a flu shot between October and early November

The change of season in October and November brings in crisp, fall weather for the majority of the United States. Many begin to look toward the holiday season to come, but few think about the impending cold weather and subsequent sickness that pops up when winter arrives.

25 Oct 2019

Most of the world unprepared for next epidemic or pandemic, GHS Index shows

No country is fully prepared for the next epidemic or pandemic, according to the first edition of the Global Health Security Index.

25 Oct 2019

Flu antibody could be a key to better treatments for severe flu disease

Researchers have found an antibody that protects mice against a wide range of lethal influenza viruses, according to a study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and Scripps Research in La Jolla, Calif.

24 Oct 2019

Optimal implementation of existing, new interventions essential to end HIV pandemic

Optimal implementation of existing HIV prevention and treatment tools and continued development of new interventions are essential to ending the HIV pandemic, National Institutes of Health experts write in a commentary Clinical Infectious Diseases.

24 Oct 2019

NIAID-supported clinical trial begins at four Vaccine and Treatment Evaluation Units

A clinical trial in which healthy adults will be deliberately infected with influenza virus under carefully controlled conditions is recruiting volunteers at four Vaccine and Treatment Evaluation Units (VTEUs) supported by NIH's National Institute of Allergy and Infectious Diseases.

24 Oct 2019

Universal influenza vaccine developed at Cornell is set for human clinical trials

A universal influenza vaccine with the potential to be longer lasting and more effective than commercially available vaccines is destined for human clinical trials, thanks to a $17.9 million grant from the National Institute of Allergy and Infectious Diseases.

24 Oct 2019

Disease/Infection News

New TB vaccine: mid-phase trials confirm safety, long-term prevention

IU researcher receives NIH grant to perform clinical trial on cirrhosis

Study sheds new light on mechanism behind evolution of antibiotic resistance

Study uses whole-genome sequencing for early identification and containment of AMR pathogens

Pro-inflammatory protein could play key role in protecting against herpes virus

Novel antibodies could provide a universal flu vaccine

Horrifying HIV epidemic in Pakistani town children due to syringe reuse

Wild polio virus strain 3 finally conquered say scientists

Newly identified antibodies could lead to better treatments and vaccines for influenza

Researchers find antibody that may protect against wide range of lethal influenza viruses

TB is not a life-long infection in most people

New analysis provides insight into dangerous conditions in U.S. immigrant detention centers

Pharma sells states on ‘Netflix model’ to wipe out hep C. But at what price?

Scientists make breakthrough in the hunt for new C. diff vaccine

UAB physicians encourage everyone to get a flu shot between October and early November

Most of the world unprepared for next epidemic or pandemic, GHS Index shows

Flu antibody could be a key to better treatments for severe flu disease

Optimal implementation of existing, new interventions essential to end HIV pandemic

NIAID-supported clinical trial begins at four Vaccine and Treatment Evaluation Units

Universal influenza vaccine developed at Cornell is set for human clinical trials

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News